Loïc Angrand

Dr. Loïc Angrand

Inserm, Paris, Île-de-France, France
orcid
PhD.OpenToWork

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Brain, Behavior, and Immunity
Verified
Journal Article
Open access
LALoïc Angrand
Loïc Angrand
WBWahid Boukouaci
Wahid Boukouaci
MLMohamed Lajnef
Mohamed Lajnef
JRJean-Romain Richard
Jean-Romain Richard
AAAna Andreazza
Ana Andreazza
RTRyad Tamouza
Ryad Tamouza
Mitochondria (Mt) are intra-cellular components essential for cellular energy processes whose dysfunction may induce premature cellular senescence and/or inflammation, both observed in bipolar disorders (BD). We investigated mitochondrial DNA copy number (mtDNAcn) levels in patients with BD being in manic, depressive or euthymic phase and in healthy controls (HC) both characterized for the levels of blood-based inflammatory markers and stigma of pathogens. 312 patients with BD were compared to 180 HC. mtDNAcn were measured using a digital droplet PCR. Serum levels of 14 inflammatory molecules and 3 anti-infectious IgG stigma were respectively evaluated by electro-chemiluminescence, ELISA and dedicated immunoassays. The statistical analyses were performed using Spearman's correlation, Wilcoxon signed-rank and Kruskal-Wallis rank sum tests. P-values were adjusted for multiple testing with Benjamini-Hochberg method. We found low levels of mtDNAcn in BD patients as compared to HC (P = 0.008) especially during manic episodes (P = 0.0002). We also observed that low levels of mtDNAcn are negatively correlated with mood and psychotic scales (PANSS, YMRS and CGI) (adjusted P (Adj P) = 0.02, 0.003 and 0.05 respectively) and positively with the GAF severity scale (Adj P = 0.002). They were also correlated with high levels of both intercellular adhesion molecule (ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 (Adj P = 0.003 and 0.001) along with a trend toward increased IL-2, IL-10 and B2M circulating levels (Adj P = 0.05). Here, we report correlations between marker of mitochondria functioning and both clinical scales and inflammatory markers in BD patients experiencing manic episodes. If replicated, these finding might allow to predict transition between disease phases and to design accurate therapeutic options.

6 July 2022 in Vaccine
Verified
Journal Article
Closed access
GBGhidaa Badran
Ghidaa Badran
LALoïc Angrand
Loïc Angrand
JMJean-Daniel Masson
Jean-Daniel Masson
GCGuillemette Crépeaux
Guillemette Crépeaux
MDMarie-Odile David
Marie-Odile David

31 August 2022 in Toxics
Verified
Journal Article
Open access
PDF file
LALoïc Angrand
Loïc Angrand
JMJean-Daniel Masson
Jean-Daniel Masson
ARAlberto Rubio-Casillas
Alberto Rubio-Casillas
MNMarika Nosten-Bertrand
Marika Nosten-Bertrand
GCGuillemette Crepeaux
Guillemette Crepeaux
Autism spectrum disorder (ASD), schizophrenia, and bipolar disorder are genetically complex and heterogeneous neurodevelopmental disorders (NDDs) resulting from genetic factors and gene-environment (GxE) interactions for which onset occurs in early brain development. Recent progress highlights the link between ASD and (i) immunogenetics, neurodevelopment, and inflammation, and (ii) impairments of autophagy, a crucial neurodevelopmental process involved in synaptic pruning. Among various environmental factors causing risk for ASD, aluminum (Al)-containing vaccines injected during critical periods have received special attention and triggered relevant scientific questions. The aim of this review is to discuss the current knowledge on the role of early inflammation, immune and autophagy dysfunction in ASD as well as preclinical studies which question Al adjuvant impacts on brain and immune maturation. We highlight the most recent breakthroughs and the lack of epidemiological, pharmacokinetic and pharmacodynamic data constituting a “scientific gap”. We propose additional research, such as genetic studies that could contribute to identify populations at genetic risk, improving diagnosis, and potentially the development of new therapeutic tools.

1 May 2021 in Toxicology
Verified
Journal Article
Closed access
LALoïc Angrand
Loïc Angrand
STSamir Takillah
Samir Takillah
IMIsabelle Malissin
Isabelle Malissin
ABAsma Berriche
Asma Berriche
CCChloe Cervera
Chloe Cervera
GBGregory Dal Bo
Gregory Dal Bo

1 March 2020 in Annales Pharmaceutiques Françaises
Verified
Journal Article
Closed access
LALoïc Angrand
Loïc Angrand
AEA.A. Elnar
A.A. Elnar
FAF.-J. Authier
F.-J. Authier
RGR.K. Gherardi
R.K. Gherardi
GCGuillemette Crepeaux
Guillemette Crepeaux